Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
07/2002
07/16/2002US6420363 Mono- or polyenic carboxylic acid derivatives
07/11/2002WO2002053546A1 Heterocycle derivatives as ppar-gamma agonists
07/11/2002WO2002008221A3 Capsaicin receptor ligands
07/11/2002US20020091119 Aralkyl and aralkylidene heterocyclic lactams and imides
07/11/2002US20020091118 Psychotherapeutic agents.
07/11/2002US20020091117 Psychotherapeutic agents.
07/11/2002CA2433779A1 Heterocycle derivatives as ppar-gamma agonists
07/10/2002CN1358174A New Compounds
07/10/2002CN1358173A Heterocyclic dicarboxylic acid diamide derivatives, agricul-horticul tural insecticides and method of using the same
07/10/2002CN1358169A N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
07/10/2002CN1358094A Method for treating chronic pain using MEK inhibitors
07/04/2002WO2002051831A1 Oxybenzamides derivatives as factor xa inhibitors
07/04/2002WO2002051397A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
07/04/2002US20020086921 Compositions stabilized by dioxopiperazinyl derivatives
07/04/2002US20020086866 Quinoxalinones as serine protease inhibitors
07/04/2002DE10063294A1 New N-(heterocyclyl-alkyl)-fused norbornylamine derivatives, are NHE3 inhibitors useful e.g. for treating respiratory disorders, renal failure, intestinal dysfunction, lipid metabolism disorders or proliferative diseases
07/03/2002EP1219607A1 Integrase inhibitors containing aromatic heterocycle derivatives
07/03/2002EP1218359A2 Piperazine compounds
07/03/2002EP0915837B1 Glyoxylic acid derivatives
07/03/2002EP0563345B1 Novel 4-arylpiperazines and 4-arylpiperidines
07/03/2002CN1356991A Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors
07/03/2002CN1356983A Tri-aryl acid derivatives as PPAR receptor ligands
07/03/2002CN1356981A Pharmaceutical compounds
07/02/2002US6414189 Crystals of [S,S]-ethylenediamine-N,N′-disuccinic acid with high bulk density and method of obtaining the same
07/02/2002US6414149 Treating diabetes, treating or preventing diabetic complications
06/2002
06/27/2002WO2002049632A1 Inhibitors against the production and release of inflammatory cytokines
06/27/2002WO2002018323A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
06/27/2002WO2002009648A3 Antimicrobial biaryl compounds
06/27/2002WO2001095856A3 Urea derivative useful as an anti-cancer agent and process for preparing same
06/27/2002US20020082449 [S,S]-ethylenediamine-N,N' -discussinic acid crystal with high bulk density and process for obtaining the same
06/27/2002US20020082263 Non-thiazolidinedione PPARgamma agonists; useful in modulation of blood glucose and the increase of insulin sensitivity in mammals
06/27/2002US20020082260 Isoindolin-1-one-substituted propionamide glucokinase activators which increase insulin secretion in the treatment of type II diabetes
06/27/2002US20020081650 Expression vectors coding protein for use in the treatment of cancer, and neovascularization defects
06/26/2002EP1217000A1 Inhibitors of factor Xa and factor VIIa
06/26/2002EP1216980A1 Carboxylic acid derivatives and drugs containing the same
06/26/2002EP1216240A1 Amide compounds
06/26/2002EP0931067B1 D4 receptor selectivity piperazine derivatives
06/26/2002CN1355793A Novel synthesis of piperazine ring
06/26/2002CN1355791A Process for production of 2-pyridylpyridine derivatives
06/26/2002CN1086569C Dehydration plant
06/25/2002US6410791 Salbutamol; respiratory system disorders
06/25/2002US6410600 Azine used as fungicides
06/25/2002US6410536 Anticoagulants
06/25/2002US6410530 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
06/25/2002US6410526 Bone disorders; restenosis; vision disorders; anticholesterol agents; anticancer, antitumor agents
06/20/2002WO2002048124A2 Piperazine derivatives
06/20/2002WO2002048106A2 Isoindolin-1-one glucokinase activators
06/20/2002WO2002048099A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
06/20/2002WO2002024681A3 Pyrazine derivatives as modulators of tyrosine kinases
06/20/2002WO2002016312A3 NOVEL COMPOUNDS INHIBITING FACTOR Xa ACTIVITY
06/20/2002US20020077455 Protease inhibitors
06/20/2002US20020077324 Novel polyhydroxypyrazine derivatives, their preparation and the pharmaceutical compostions which comprise them
06/20/2002DE10063008A1 Carbonsäureamidderivate Carboxamide
06/20/2002DE10060807A1 Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Ortho, ortho-substituted nitrogen-containing Bisarylverbindungen, processes for their preparation, their use as a medicine as well as pharmaceutical compositions containing them
06/20/2002CA2431766A1 Carboxymide derivatives and their use in the treatment of thromboembolic diseases and tumours
06/19/2002EP1214303A1 Heterocyclic compounds and methods of use thereof
06/19/2002EP1214293A1 Non-peptidic cyclophilin binding compounds and their use
06/19/2002EP1214292A1 Tyrosine derivatives
06/19/2002EP1214287A1 Amides as inhibitors for pyruvate dehydrogenase
06/18/2002US6407248 α-unsaturated amines, their production and use
06/18/2002US6407110 Polyhydroxyalkylpyrazine derivatives and their preparation and medicines containing them
06/18/2002US6407104 Pyrrolo[1,2-a]pyrazine spla2 inhibitor
06/18/2002CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents
06/13/2002WO2002046167A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands
06/13/2002WO2002046162A1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
06/13/2002WO2002046160A2 Process for making a thrombin inhibitor
06/13/2002WO2002028842A3 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonist
06/13/2002WO2002004404A3 7,8 and 9-substituted tetracycline compounds
06/13/2002US20020072601 Reacting a tricyclic diketopiperazine with a nucleophillic compound to form amino acid derivative
06/13/2002US20020072519 Useful as psychotherapeutic agents
06/13/2002US20020072516 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders
06/13/2002US20020071874 Compositions containing therapeutically active components having enhanced solubility
06/13/2002CA2435467A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands
06/13/2002CA2430842A1 Process for making a thrombin inhibitor
06/12/2002EP1212302A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors
06/12/2002EP1212269A1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
06/12/2002EP1178972A4 Novel synthesis of piperazine ring
06/12/2002EP0885204B1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
06/12/2002EP0873320B1 Piperazine derivatives as tachykinin antagonists
06/12/2002EP0652867B1 Novel pyridyl- and pyrimidylpiperazine derivatives
06/12/2002CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds
06/11/2002US6403738 Polymerization of olefins
06/11/2002US6403595 Anticoagulants
06/11/2002US6403592 Serotonin reuptake inhibitors
06/11/2002US6403589 Nucleoside transport inhibitor
06/11/2002US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and
06/06/2002US20020068687 Methods and compositions for inhibiting cell proliferative disorders
06/05/2002EP1211249A1 Novel thiazine or pyrazine derivatives
06/05/2002EP1210340A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments
06/05/2002EP0923539B1 Compounds with growth hormone releasing properties
06/05/2002EP0711282B1 Compounds as pde iv and tnf inhibitors
06/05/2002CN1352638A Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same
06/04/2002US6399614 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
06/04/2002US6399613 N,n'-bis(2-hydroxyethyl)pyrazine-2,5- or -2,6-dicarboxamide; diabetes
06/04/2002US6399223 Compound for use in organic EL device and organic EL device
06/04/2002CA2248366C Quinoxalinediones
05/2002
05/30/2002WO2002043449A1 Luminescent element material and luminescent element comprising the same
05/30/2002WO2002042250A1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES
05/30/2002US20020065415 For treating cerebral ischemia or cerebral infarction resulting from thromboembolic or hemorrhagic stroke, cerebral vasospasms, hypoglycemia, cardiac arrest, neurodegenerative disorders
05/29/2002EP1208097A2 Substituted oxoazaheterocyclyl compounds